Alphagenics is one of the most qualified national companies in the use of innovative molecular biology techniques, suitable both for clinical use and research in the medical and environmental fields, for the in-depth analysis of prognostic/diagnostic issues.
Aphagenics focuses on the research, development and production of testing kits. The company provides consulting services for the technology transfer of new projects, and its R&D department is engaged in the development of new technologies and the design of custom solutions to fully meet the market’s needs. The company has developed different systems for the molecular typing and quantification of viral genomes (HPV/HCV) using reverse dot/blot, real-time PCR and ELISA methodologies. The company also offers a full panel of prognostic kits, based mainly on real-time PCR technology, for some of the most important cancers, such as kits for colon and gastric carcinoma (ARKRAS e ACMSi), thyroid, colon and melanoma cancer (ARBRAF), glioblastoma (ARMGMt), lung cancer (A lEGFR) and an innovative prognostic kit that provides the probability of breast cancer recurrence (ARBREASt). Tests are highly reproducible, sensitive and rapid.
Alphagenics Biotech S.r.l
Statale 14 km 169,5
AREA Science Park Basovizza, Edificio Q1